Paion’s ‘ultra-short-acting’ anaesthetic Byfavo has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for use in procedural sedation.
The committee for human medicinal products recommended AstraZeneca’s COVID-19 vaccine be granted conditional marketing authorisation alongside 12 other approvals.